What is the significance of an antistreptolysin O (ASO) titer less than 20 IU/mL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antistreptolysin O Titer <20 IU/mL: Clinical Significance

An ASO titer less than 20 IU/mL is well below the normal upper limit and essentially rules out recent or past Group A Streptococcal (GAS) infection, making it clinically insignificant for diagnosing streptococcal-related conditions.

Understanding the Result

This value is extremely low and falls far below established normal ranges across all studied populations. To put this in context:

  • Normal upper limits vary by population but typically range from 200-515 IU/mL in healthy children 1, 2, 3
  • Your value of <20 IU/mL represents essentially no antibody response to streptococcal antigens
  • This effectively excludes recent GAS infection or its sequelae

Clinical Implications

What This Rules Out

An ASO <20 IU/mL makes the following diagnoses extremely unlikely:

  • Acute Rheumatic Fever (ARF) - requires evidence of preceding GAS infection
  • Post-streptococcal glomerulonephritis
  • Recent streptococcal pharyngitis (within past 2-6 weeks)

Critical Guideline Context

Anti-streptococcal antibody titers are NOT recommended for diagnosing acute pharyngitis because they reflect past, not current events 4. The IDSA guidelines (2012) provide strong, high-quality evidence that:

  • ASO titers should never be used to diagnose active streptococcal pharyngitis
  • Throat culture or rapid antigen detection test (RADT) are the appropriate diagnostic tools for acute infection
  • Antibody titers are only useful for diagnosing non-suppurative sequelae like ARF or post-streptococcal glomerulonephritis 4

Important Caveats

Timing Matters

ASO titers rise approximately 1 week after infection and peak at 3-6 weeks 5. Therefore:

  • A low titer does not rule out very early infection (first week)
  • For suspected recent GAS infection, use throat culture/RADT instead 4

Single Measurement Limitations

A single ASO measurement has limited diagnostic value 5. Best practice requires:

  • Two sequential measurements showing a rising titer (≥2-fold increase)
  • Simultaneous measurement of anti-DNase B antibody for increased sensitivity
  • Clinical correlation with symptoms and timing

When ASO May Be Falsely Low

Even with true GAS infection, ASO may not rise in:

  • Very early infection (<1 week)
  • Patients on prophylactic penicillin (suppresses antibody response) 2
  • Some individuals who simply don't mount robust antibody responses

Practical Interpretation

For your specific result of <20 IU/mL:

  • If evaluating for acute pharyngitis: This test is inappropriate; use throat culture/RADT 4
  • If evaluating for ARF or post-streptococcal complications: This low titer argues strongly against recent GAS infection
  • If patient has current symptoms: The low ASO is irrelevant—diagnose acute infection with appropriate tests
  • If considering chronic GAS carrier state: ASO titers remain low in carriers experiencing viral pharyngitis 4

Bottom Line

An ASO <20 IU/mL is a non-contributory result that indicates no significant streptococcal antibody response. It should not drive clinical decision-making for acute infections, and its interpretation must always be placed within the proper clinical context of timing, symptoms, and the specific diagnostic question being asked.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.